Putting chips on the table

After another day of market brutality, I'm putting a bit more cash to work. Unfortunately I should have been more dedicated to my last post and sold of positions mentioned. Tough luck, instead I'm now buying a bit more of the beaten down stocks. Especially I think the Vestas annual report today looked good and the Pandora as well. The …

Read more.

---

2 gode signaler at købe på

Mens aktierne har fortsat sin nedtur i februar minder vi om at det fortsat i investerings øjemed er vigtigst at holde øjnene på de fundamentale nøgletal.  Det kan være svært når selv gode selskaber med gode regnskaber bliver mødt med sell-off i disse tider.  Men hvis man har en længere horisont så er det tilbudstid på børserne verden over.  P/e …

Read more.

---
Buying and selling is the new black?

Buying and selling is the new black?

Given the volatile start to 2016 in almost any market across the world, I believe there is an opportunity to be a bit more active in the near future. I'm considering to shed some of the recent acquisitions and add-ons again in the near future at slightly higher levels than the current. I'm looking for a 10 % profit, so …

Read more.

The gateway to small- and midcap stocks in Scandinavia. Steen has more than 15 years hands-on expericence in analysing and investing in stocks. He is a weekly contributor and analyst in “Aktieugebrevet”, one of the leading sources of independent analysis in Denmark.

Peter Hildebrandt, also known as “Akademikeren”, has been investing for more than 17 years. Mainly invests in Undervalued technology and biotech stocks and is currently rotating towards dividend stocks in energy and shipping.

I’m a ten year veteran of biotechnology, and currently pursuing my MBA from UCLA.  I use my knowledge of the industry and business to make my investing decisions.  I look for small to mid-cap biotech companies with innovative research and buy into their company during clinical trials.

Andreas is providing stock tips with deep fundamental research behind each stock he recommends. He is privately a portfolio manager at his own Investment company where he Invest in stocks, options, CFD’s etc. with a balanced long/short approach.

Jacob’s approach is to search for that which is undervalued and where the discount to the intrinsic value provides a large margin of safety. He believes sectors that are either out of favor or in distress typically offer the best opportunities.